More than 170 million people worldwide are infected with hepatitis C. The US biopharmaceuticals company Gilead has been charging between 700 and 900 euros per pill. The drugs are big money-makers. Sovaldi has to be combined with other medications - a two-three month treatment costs up to 108,000 euros. How much should patients have to pay for medications that can cure?